Theresa Wingrove

Track

Insider profile

Currently holds a position at ImmunoGen Inc

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 52% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President - Regulatory Affairs and Quality ImmunoGen Inc Feb. 1, 2017 -
Vice President - Regulatory Affairs ImmunoGen Inc Jan. 18, 2011 - Jan. 1, 2017
Theresa Wingrove's trades of ImmunoGen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-06 2024-02-05
US ImmunoGen Inc (IMGN)
PlS Planned sale
94,101 +2.8%
61.43
US$4,195,482 		94,101 +2.8% 61.43 US$4,195,482
2024-02-05 2024-02-05
US ImmunoGen Inc (IMGN)
PrS Proposed sale
14,440
135.35
US$664,328 		14,440 135.35 US$664,328
2024-01-18 2024-01-16
US ImmunoGen Inc (IMGN)
PlS Planned sale
40,547 -22.6%
410.00
US$3,193,388 		40,547 -22.6% 410.00 US$3,193,388
2024-01-16 2024-01-16
US ImmunoGen Inc (IMGN)
PrS Proposed sale
187,667
29.64
US$5,561,602 		187,667 29.64 US$5,561,602
2023-12-19 2023-12-15
US ImmunoGen Inc (IMGN)
PlS Planned sale
117,445 -97.7%
29.40
US$3,452,883 		117,445 -97.7% 29.40 US$3,452,883
2023-12-15 2023-12-15
US ImmunoGen Inc (IMGN)
PrS Proposed sale
117,445
29.40
US$3,452,459 		117,445 29.40 US$3,452,459
2023-12-01 2023-11-30
US ImmunoGen Inc (IMGN)
PlS Planned sale
164,424 -98.3%
28.95
US$4,760,075 		164,424 -98.3% 28.95 US$4,760,075
2023-11-30 2023-11-30
US ImmunoGen Inc (IMGN)
PrS Proposed sale
164,424
28.95
US$4,759,955 		164,424 28.95 US$4,759,955
2023-12-01 2023-11-29
US ImmunoGen Inc (IMGN)
PlS Planned sale
6,792 -70.7%
16.66
US$113,155 		6,792 -70.7% 16.66 US$113,155
2023-11-29 2023-11-29
US ImmunoGen Inc (IMGN)
PrS Proposed sale
6,792
16.66
US$113,157 		6,792 16.66 US$113,157
2023-11-17 2023-11-15
US ImmunoGen Inc (IMGN)
PlS Planned sale
166,725 -98.3%
15.85
US$2,642,591 		166,725 -98.3% 15.85 US$2,642,591
2023-11-15 2023-11-15
US ImmunoGen Inc (IMGN)
PrS Proposed sale
166,725
15.85
US$2,643,143 		166,725 15.85 US$2,643,143
2023-11-08 2023-11-07
US ImmunoGen Inc (IMGN)
PlS Planned sale
19,517 -87.4%
16.66
US$325,153 		19,517 -87.4% 16.66 US$325,153
2023-11-07 2023-11-07
US ImmunoGen Inc (IMGN)
PrS Proposed sale
19,517
16.66
US$325,081 		19,517 16.66 US$325,081
2023-10-18 2023-10-16
US ImmunoGen Inc (IMGN)
S Sale
192,004 -98.6%
14.40
US$2,764,858 		192,004 -98.6% 14.40 US$2,764,858
2023-10-16 2023-09-15
US ImmunoGen Inc (IMGN)
PrS Proposed sale
192,004
14.40
US$2,764,597 		192,004 14.40 US$2,764,597
2023-09-19 2023-09-15
US ImmunoGen Inc (IMGN)
S Sale
192,013 -98.6%
15.44
US$2,964,681 		192,013 -98.6% 15.44 US$2,964,681
2023-09-15 2023-09-15
US ImmunoGen Inc (IMGN)
PrS Proposed sale
192,013
15.44
US$2,965,492 		192,013 15.44 US$2,965,492
2020-02-25 2020-02-24
US ImmunoGen Inc (IMGN)
PlS Planned sale
16,147 -18.6%
4.99
US$80,574 		16,147 -18.6% 4.99 US$80,574
2019-02-25 2018-02-22
US ImmunoGen Inc (IMGN)
PlS Planned sale
11,032 -11.9%
5.60
US$61,779 		11,032 -11.9% 5.60 US$61,779
2018-02-23 2018-02-21
US ImmunoGen Inc (IMGN)
PlS Planned sale
11,379 -11.2%
10.88
US$123,804 		11,379 -11.2% 10.88 US$123,804